Heart signals may reveal if a common AFib procedure will last

NCT ID NCT07721948

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial investigates whether analyzing electrical signals from the heart during pulsed field ablation can tell doctors how well the catheter is touching tissue and whether the resulting scar will be permanent. About 60 people with paroxysmal atrial fibrillation will undergo the procedure, and researchers will compare signal changes to findings from a repeat mapping procedure months later. The goal is to improve the durability of pulmonary vein isolation, the cornerstone of AFib treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Pulsed field ablation with a circular single-shot catheter
What this could lead to
If successful, this could help doctors perform more durable ablations for atrial fibrillation, potentially reducing repeat procedures.
What could go wrong
This is a small, early-stage study focused on measuring signals, not on patient outcomes. The method may not reliably predict long-term success.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Medical Centre Ljubljana

    Ljubljana, 1000, Slovenia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.